Ishita Drugs & Industries informs about annual secretarial compliance report

11 May 2022 Evaluate

Ishita Drugs & Industries has informed that Annual Secretarial Compliance Report under Regulation 24(A) of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 is not applicable to the company.

The above information is a part of company’s filings submitted to BSE.

Ishita Drugs & Inds. Share Price

70.45 0.70 (1.00%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.